Systemic and Direct Nose-to-Brain Transport Pharmacokinetic Model for Remoxipride after Intravenous and Intranasal Administration

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Drug Metabolism And Disposition

• Publication date

  2011-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/dmd.111.040782PMID 21903866
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intranasal delivery to the central nervous system: mechanisms and experimental considerations.

  2010influential reference
• Online solid phase extraction with liquid chromatography-tandem mass spectrometry to analyze remoxipride in small plasma-, brain homogenate-, and brain microdialysate samples.

  2010cited by this paper
• Assessment of the blood-brain barrier in CNS drug discovery.

  2010cited by this paper
• Receptor Occupancy and Brain Free Fraction

  2009cited by this paper
• A New Minimal-Stress Freely-Moving Rat Model for Preclinical Studies on Intranasal Administration of CNS Drugs

  2009influential reference
• Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research.

  2008cited by this paper
• Extensions to the Visual Predictive Check to facilitate model performance evaluation

  2008cited by this paper
• AAPS-FDA workshop white paper: Microdialysis principles, application, and regulatory perspectives report from the Joint AAPS-FDA Workshop, November 4–5, 2005, Nashville, TN

  2007cited by this paper
• AAPS-FDA Workshop White Paper: Microdialysis Principles, Application and Regulatory Perspectives

  2006influential reference
• Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling

  2005cited by this paper
• Dopamine D2 blocking activity and plasma concentrations of remoxipride and its main metabolites in the rat

  2005cited by this paper
• Pharmacokinetics and effects on prolactin of remoxipride in patients with tardive dyskinesia

  2005cited by this paper
• Nasal drug administration: potential for targeted central nervous system delivery.

  2005cited by this paper
• Transneuronal transport of peroxidase-conjugated wheat germ agglutinin (WGA-HRP) from the olfactory epithelium to the brain of the adult rat

  2004influential reference
• Is nose‐to‐brain transport of drugs in man a reality?

  2004cited by this paper
• Effect of urinary pH on the plasma and urinary kinetics of remoxipride in man

  2004cited by this paper
• Uptake of estradiol or progesterone into the CSF following intranasal and intravenous delivery in rats.

  2004cited by this paper
• The potential of nasal application for delivery to the central brain-a microdialysis study of fluorescein in rats.

  2004cited by this paper
• Considerations in the Use of Cerebrospinal Fluid Pharmacokinetics to Predict Brain Target Concentrations in the Clinical Setting

  2002cited by this paper
• Visualization of In Vivo Olfactory Uptake and Transfer Using Fluorescein Dextran

  2002cited by this paper
• Microdialysis for pharmacokinetic analysis of drug transport to the brain.

  1999cited by this paper
• High sensitivity determination of the remoxipride hydroquinone metabolite NCQ-344 in plasma by coupled column reversed-phase liquid chromatography and electrochemical detection.

  1998cited by this paper
• Delivery of 125I-NGF to the Brain via the Olfactory Route

  1997cited by this paper
• In vivo effects of remoxipride and aromatic ring metabolites in the rat.

  1997cited by this paper
• Dextromethorphan O-demethylase activity in rat brain microsomes.

  1995cited by this paper
• The ependyma: A protective barrier between brain and cerebrospinal fluid

  1995cited by this paper
• The ependyma: A protective barrier between brain and cerebrospinal fluid

  1995cited by this paper
• Application of intracerebral microdialysis to study regional distribution kinetics of drugs in rat brain

  1995cited by this paper
• Aplastic anaemia and remoxipride.

  1993cited by this paper
• Disposition of remoxipride in different species. Species differences in metabolism.

  1993cited by this paper
• Biochemical pharmacology of the atypical neuroleptic remoxipride

  1991cited by this paper
• Biochemical pharmacology of the atypical neuroleptic remoxipride

  1990cited by this paper
• Distribution of remoxipride to the human brain and central D2‐ dopamine receptor binding examined in vivo by PET

  1990cited by this paper
• Nasal systemic drug delivery

  1989cited by this paper
• Ionic Composition of Microdialysis Perfusing Solution Alters the Pharmacological Responsiveness and Basal Outflow of Striatal Dopamine

  1989influential reference

• Overcoming translational barriers in nose-to-brain drug delivery for clinical applications.

  2026cites this paper
• Intranasally Delivered Mesenchymal Stem Cells Reverses Prodromal Non-Motor Deficits and Nigral Loss in a Parkinson’s Disease Mouse Model

  2026cites this paper
• Intranasal sertraline for the investigation of nose-to-brain delivery to mitigate systemic exposure

  2025cites this paper
• Pharmacokinetics of intranasal drugs, still a missed opportunity?

  2024cites this paper
• Advances in Aerosol Formulation for Targeted Delivery of Therapeutic Agents from Nose to Brain.

  2024cites this paper
• Exploring the Potential of Nasal Drug Delivery for Brain Targeted Therapy: A Detailed Analysis

  2024cites this paper
• Improving drug delivery to the brain: the prodrug approach

  2024cites this paper
• Exploring Kp,uu,BBB Values Smaller than Unity in Remoxipride: A Physiologically-Based CNS Model Approach Highlighting Brain Metabolism in Drugs with Passive Blood-Brain Barrier Transport

  2024cites this paper
• Development of a pharmacokinetic and pharmacodynamic model for intranasal administration of midazolam in older adults: a single-site two-period crossover study.

  2023cites this paper
• Donepezil Brain and Blood Pharmacokinetic Modeling after Nasal Film and Oral Solution Administration in Mice

  2023influential citation
• Drug toxicity and forensic pharmacokinetics

  2022cites this paper
• AmyP53, a Therapeutic Peptide Candidate for the Treatment of Alzheimer’s and Parkinson’s Disease: Safety, Stability, Pharmacokinetics Parameters and Nose-to Brain Delivery

  2022cites this paper
• Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System

  2022cites this paper
• Quantitative and qualitative analysis of direct nose-to-brain drug delivery

  2021cites this paper
• Direct transport theory: From the nose to the brain

  2021cites this paper
• Nasotransmucosal Delivery of Curcumin-Loaded Mucoadhesive Microemulsions for Treating Inflammation-Related CNS Disorders.

  2021cites this paper
• Nasotransmucosal delivery of curcumin-loaded mucoadhesive microemulsion for treating inflammation-related CNS disorders Enflamasyonla ilişkili CNS bozukluklarının tedavisi için kurkumin yüklü mukoadezif mikroemülsiyonun nazotransmukozal yoldan uygulanması

  2021cites this paper
• Controlled Drug Delivery via the Nasal Route

  2021cites this paper
• Nanostructure self-assembly for direct nose-to-brain drug delivery

  2020cites this paper
• A Computational Systems Approach to Rational Design of Nose-to-Brain Delivery of Biopharmaceutics

  2020cites this paper
• Nose-to-Brain Delivery of Diazepam from an Intranasal Aqua-Triggered In-Situ (ATIS) Gelling Microemulsion: Monitoring Brain Uptake by Microdialysis

  2020cites this paper
• Cachexia: Pathophysiology and Ghrelin Liposomes for Nose-to-Brain Delivery

  2020cites this paper
• Non-Invasive Strategies for Nose-to-Brain Drug Delivery

  2020cites this paper
• A REVIEW ON NASAL DRUG DELIVERY SYSTEM AND ITS CONTRIBUTION IN THERAPEUTIC MANAGEMENT

  2019cites this paper
• Mathematical Modeling and Simulation to Investigate the CNS Transport Characteristics of Nanoemulsion-Based Drug Delivery Following Intranasal Administration

  2019cites this paper
• Updates on thermosensitive hydrogel for nasal, ocular and cutaneous delivery

  2019cites this paper
• The need for mathematical modelling of spatial drug distribution within the brain

  2019cites this paper
• Recent advances in carrier mediated nose‐to‐brain delivery of pharmaceutics

  2018cites this paper
• Improving the Prediction of Local Drug Distribution Profiles in the Brain with a New 2D Mathematical Model

  2018cites this paper
• Transnasomucosal mucoadhesive microemulsion of zaltoprofen: A comparative brain distribution study

  2017cites this paper
• Predicting Drug Concentration‐Time Profiles in Multiple CNS Compartments Using a Comprehensive Physiologically‐Based Pharmacokinetic Model

  2017cites this paper
• Industrial medicinal chemistry insights: neuroscience hit generation at Janssen.

  2017cites this paper
• Teaser Modern medicinal chemistry impacts drug discovery in many ways beyond just optimization of clinical candidates

  2017cites this paper
• Demonstration of Direct Nose-to-Brain Transport of Unbound HIV-1 Replication Inhibitor DB213 Via Intranasal Administration by Pharmacokinetic Modeling

  2017cites this paper
• Intranasal delivery of antipsychotic drugs.

  2017cites this paper
• Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion.

  2017cites this paper
• Sedative and cardiovascular effects of intranasal or intramuscular dexmedetomidine in healthy dogs.

  2017influential citation
• Microdialysis: the Key to Physiologically Based Model Prediction of Human CNS Target Site Concentrations

  2017cites this paper
• Intracerebral microdialysis in blood-brain barrier drug research with focus on nanodelivery.

  2016cites this paper
• A comparison of two semi-mechanistic models for prolactin release and prediction of receptor occupancy following administration of dopamine D2 receptor antagonists in rats.

  2016cites this paper
• Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain Metastases

  2016cites this paper
• Brain targeting by intranasal drug delivery (INDD): a combined effect of trans-neural and para-neuronal pathway

  2016cites this paper
• Revealing the Neuroendocrine Response After Remoxipride Treatment Using Multi-Biomarker Discovery and Quantifying It by PK/PD Modeling

  2016cites this paper
• Summary data of potency and parameter information from semi-mechanistic PKPD modeling of prolactin release following administration of the dopamine D2 receptor antagonists risperidone, paliperidone and remoxipride in rats

  2016cites this paper
• Brain targeting efficiency of Curcumin loaded mucoadhesive microemulsion through intranasal route

  2016cites this paper
• Still NAAG'ing After All These Years: The Continuing Pursuit of GCPII Inhibitors.

  2016cites this paper
• A Generic Multi-Compartmental CNS Distribution Model Structure for 9 Drugs Allows Prediction of Human Brain Target Site Concentrations

  2016cites this paper
• Formulation and device design to increase nose to brain drug delivery

  2016cites this paper
• Emerging Insights for Translational Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Studies: Towards Prediction of Nose-to-Brain Transport in Humans

  2015influential citation
• Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration

  2015cites this paper
• Drug transporters in the nasal epithelia and their contribution in drug delivery

  2014cites this paper
• Intranasal Drug Delivery to the Brain

  2014cites this paper
• The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview.

  2014cites this paper
• PKPD Aspects of Brain Drug Delivery in a Translational Perspective

  2014cites this paper
• The mastermind approach to CNS drug therapy: translational prediction of human brain distribution, target site kinetics, and therapeutic effects

  2013cites this paper
• Translational Approaches for Predicting CNS Drug Effects Using Microdialysis

  2013cites this paper
• Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research.

  2013cites this paper
• Intranasal and Subcutaneous Administration of Dopamine D3 Receptor Agonists Functionally Restores Nigrostriatal Dopamine in MPTP-Treated Mice

  2013cites this paper
• Intranasal drug delivery to the central nervous system: present status and future outlook.

  2012cites this paper
• Mechanism-based PK–PD model for the prolactin biological system response following an acute dopamine inhibition challenge: quantitative extrapolation to humans

  2012cites this paper
• Drug development of intranasally delivered peptides.

  2012cites this paper
• Multi-biomarker pharmacokinetic-pharmacodynamic relationships of central nervous systems active dopaminergic drugs

  year unknowninfluential citation